Welcome to NZBIO

 

NZBIO is a vibrant member-based organisation focused on growing New Zealand’s prosperous bioeconomy.  With hundreds of individual and corporate members from across agbiotech, human health, industrial and environmental and food bioscience, NZBIO plays a leading role in providing practical support for companies to grow.  

NZBIO’s activities include member events, seminars and conferences, policy advocacy, national and international outreach and promotion.Our membership base ranges from start up bioscience companies, to mature corporates and major multinationals.  We also represent New Zealand research institutes and universities, specialist service professionals, corporate, institutional, individual and student members from New Zealand and around the world.

Join Us

Latest News   

 

BioSA Incubator boosts SA job growth 22 Aug 2014 - BioSA Incubator boosts SA job growth The BioSA incubator is the first dedicated bioscience incubator in Australia, which is aimed at promoting and accelerating the commercialisation of research and development in South Australia.
Pacific Edge 2014 Annual Meeting of Shareholders 21 Aug 2014 - Pacific Edge 2014 Annual Meeting of Shareholders Good afternoon and welcome to the 2014 Pacific Edge Annual Meeting of Shareholders. My name is Chris Swann and I am the chairman of the Pacific Edge Board.
Hill Laboratories appoints new Agricultural Divisional Manager 21 Aug 2014 - Hill Laboratories appoints new Agricultural Divisional Manager New Zealand's leading analytical testing laboratory, Hill Laboratories, has appointed Dr Bart Challis as new Agricultural Divisional Manager for the company.
Global computational biology market to grow at CAGR of 21.3% to become $2937.3 million by 2018 21 Aug 2014 - Global computational biology market to grow at CAGR of 21.3% to become $2937.3 million by 2018 In its latest market research report published recently, Transparency Market Research, a U.S.-based market intelligence firm states that the global computational biology market is estimated to be worth US$2937.3 million by 2018.
Seabed solution for cold sores 20 Aug 2014 - Seabed solution for cold sores The blue blood of abalone, a seabed delicacy could be used to combat common cold sores and related herpes virus following breakthrough research at the University of Sydney.
Why CSL chose high cost Switzerland over high cost Australia 18 Aug 2014 - Why CSL chose high cost Switzerland over high cost Australia The country’s largest biotechnology manufacturer CSL says Australia urgently needs a plan to become more competitive or risk being ignored altogether when companies decide where to invest.
The world 15 Aug 2014 - The world's smallest apple It took a decision from the United Nations before Havelock North grower Phil Alison could call his Rockit miniature apples, apples.
Would you like genetically edited fruit in a bowl on your table? 15 Aug 2014 - Would you like genetically edited fruit in a bowl on your table? Consumers are notoriously chary about ‘genetically modified’ foods. Would they be equally cautious about ‘genetically edited’ produce?